ElevateBio, founded in 2019 and headquartered in Cambridge, Massachusetts is creating and operating a portfolio of cell and gene therapy companies through partnerships with innovative scientists and inventors.
| Website | http://elevate.bio |
| Revenue | $105.7 million |
| Funding | $1.2 billion |
| Employees | View employees |
| Founded | 2017 |
| Address | 225 Wyman St, Waltham, Massachusetts 02451, US |
| Industry | Business Services General, Biotechnology, Drug Delivery, Business Services, Science and Engineering, Drug Discovery |
| Competitors | Adverum Biotechnologies, Celularity Inc., REGENXBIO Inc., Lyell Immunopharma, Aspyrian Therapeutics, Inc, Homology Medicines, Inc. (view competitors) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies, SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 5417 Companies, NAICS Code 541713 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 541 Companies |
Looking for a particular Elevate Bio employee's phone or email?
The Elevate Bio annual revenue was $105.7 million in 2026.
Elevate Bio is based in Waltham, Massachusetts.
The NAICS codes for Elevate Bio are [5417, 541713, 325, 32, 54, 54171, 3254, 32541, 541].
The SIC codes for Elevate Bio are [87, 873, 28, 283].